Yanteng Xu
Guangzhou, 510630, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Countering postoperative immune suppression with a self-assembling dendritic cell nanovaccine.
Journal: Bioactive materials
Published: February 24, 2026
Nanoceria drive stem cell hepatic differentiation and microenvironment remodeling for acute liver failure therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 07, 2026
An Implantable Scaffold Sequentially Releasing STING Agonist and B7-H3 Antibody for Bone Metastasis Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 16, 2025
Nanovesicles integrating PD-1-mediated targeting and CRISPR/Cas9-based CD47 editing for dual immune checkpoint blockade.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 12, 2025
Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma.
Journal: Biomaterials
Published: June 01, 2025
Microfluidic fabricated cell-laden microgels aggregated into artificial liver microtissue to ameliorate drug-induced liver injury.
Journal: Biomaterials
Published: April 18, 2025
Implantable hydrogel-based scaffold integrating cascaded chemotherapy and self-amplified immunotherapy to suppress postsurgical tumor recurrence.
Journal: Journal of colloid and interface science
Published: March 25, 2025
Mesenchymal stromal/stem cell spheroid-derived extracellular vesicles advance the therapeutic efficacy of 3D-printed vascularized artificial liver lobules in liver failure treatment.
Journal: Bioactive materials
Published: September 09, 2024
Last Updated: 09/26/2026